Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010

Anaerobe

Volumn 28, Issue , 2014, Pages 13-17

  Obuch Woszczatyński, Piotr ^a   Lachowicz, Dominika ^a   Schneider, Anna ^b   Mól, Anna ^b   Pawłowska, Jolanta ^c   Ozdzeńska Milke, Ewa ^d   Pruszczyk, Piotr ^d   Wultańska, Dorota ^a   Młynarczyk, Grazyna ^a   Harmanus, Celine ^e   Kuijper, Ed J ^e   van Belkum, Alex ^f   Pituch, Hanna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b University Hospital of Lord's Transfiguration   (Poland)

^c Diagnostic Laboratory Provincial Hospital in P ock   (Poland)

^d Clinical Department of Neurosurgery with Motor System Traumatology Unit   (Poland)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f BIOMÉRIEUX   (France)

Author keywords

Clostridium difficile infection; Outbreak; PCR ribotype 027; PCR ribotype 176

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; CLOSTRIDIUM TOXIN; ERYTHROMYCIN; GATIFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL TOXIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLON DISEASE; COLONIC WALL THICKENING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH; DIARRHEA; DISEASE SEVERITY; DRUG SENSITIVITY; EPIDEMIC; ERMB GENE; FECES ANALYSIS; FEMALE; FEVER; HOSPITAL INFECTION; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STRAIN DIFFERENCE; TOXIC MEGACOLON; UNSPECIFIED SIDE EFFECT; VERY ELDERLY; CLASSIFICATION; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; GENETICS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; RIBOTYPING;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DIARRHEA; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; POLAND; POLYMERASE CHAIN REACTION; RIBOTYPING;

EID: 84900337483     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2014.04.007     Document Type: Article

References (18)

1. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009, 7:526-536.
2. Kuehne S.A., Cartman S.T., Minton N.P. Both, toxin A and toxin B, are important in Clostridium difficile infection. Gut Microbes 2011, 2:252-255.
3. Rupnik M., Grabnar M., Geric B. Binary toxin producing Clostridium difficile strains. Anaerobe 2003, 9:289-294.
4. Kuijper E.J., Coignard B., Tüll P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006, 12(Suppl.6):2-18. ESCMID study Group for Clostridium difficile EU Member States European Centre for Disease Prevention and Control.
5. Kuijper E.J., Barbut F., Brazier J.S., Kleinkauf N., Eckmanns T., Lambert M.L., et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe. Euro Surveill 2008, 13(31). pii:18942.
6. Arvand M., Hauri A.M., Zaiss N.H., Witte W., Bettge-Weller G. Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C.difficile infection in Hesse, Germany. Euro Surveill 2009, 14(45). pii:19403.
7. Merrigan M., Venugopal A., Mallozzi M., Roxas B., Viswanathan V.K., Johnson S., et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. JBacteriol 2010, 192:4904-4911.
8. Clements A.C., Magalhães R.J., Tatem A.J., Paterson D.L., Riley T.V. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis 2010, 10:395-404.
9. Borgmann S., Jakobiak T., Gruber H., Reil M., Schroder H., Kist M., et al. Association of ciprofloxacin prescriptions to outpatients to Clostridium difficile infections. Euro Surveill 2010, 15(5). pii:19479.
10. Carman R.J., Genheimer C.W., Rafii F., Park M., Hiltonsmith M.F., Lyerly D.M. Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea. Anaerobe 2009, 15:244-248.
11. Pituch H., Bakker D., Kuijper E., Obuch-Woszczatyński P., Wultańska D., Nurzyńska G., et al. First isolation of Clostridium difficile PCR-ribotype 027/toxinotype III in Poland. Pol J Microbiol 2008, 57:267-268.
12. Nyč O., Pituch H., Matějková J., Obuch-Woszczatynski P., Kuijper E.J. Clostridium difficile PCR ribotype 176 in the Czech Republic and Poland. Lancet 2011, 377(9775):1407.
13. Carman R.J., Wickham K.N., Chen L., Lawrence A.M., Boone J.H., Wilkins T.D., et al. Glutamate dehydrogenase is highly conserved among Clostridium difficile ribotypes. JClin Microbiol 2012, 50:1425-1426.
14. Pituch H., van Leeuwen W., Maquelin K., Wultańska D., Obuch-Woszczatyński P., Nurzyńska G., et al. Toxin profiles and resistances to macrolides and newer fluoroquinolones as epidemicity determinants of clinical isolates of Clostridium difficile from Warsaw, Poland. JClin Microbiol 2007, 45:1607-1610.
15. Pituch H., Obuch-Woszczatyński P., Wultańska D., Nurzyńska G., Harmanus C., Banaszkiewicz A., et al. Characterization and antimicrobial susceptibility of Clostridium difficile strains isolated from adult patients with diarrhoea hospitalized in two university hospitals in Poland, 2004-2006. JMed Microbiol 2011, 60:1200-1205.
16. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Breakpoint tables for interpretation of MICs and zone diameters 2012, 62-63. Version 2.0, valid from 2012-01-01.
17. Curry S.R., Marsh J.W., Shutt K.A., Muto C.A., O'Leary M.M., Saul M.I., et al. High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital. Clin Infect Dis 2009, 48:425-429.
18. Bauer M.P., Notermans D.W., van Benthem B.H., Brazier J.S., Wilcox M.H., Rupnik M., et al. ECDIS Study Group. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377(9759):63-73.